# RECURSION PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/recursion-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-26T04:46:04.593285+00:00 | | Last reviewed | 2026-10-26T04:46:04.593285+00:00 | ## Identity - Legal name: RECURSION PHARMACEUTICALS, INC. - Display name: RECURSION PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-26T04:46:04.593285+00:00 | | Completeness | 0.409 | | Record Quality | 0.838 | | Directors | 17 | | Committees | 1 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Blake Borgeson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2013-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:5 - Christopher Gibson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2013-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:7 - Dean Y. Li: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2013-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:8 - Elaine Sun: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:10 - Franziska Michor: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:11 - Najat Khan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:13 - Namandjé Bumpus: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:15 - Robert Hershberg: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:17 - Zachary Bogue: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:19 - Zavain Dar: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:21 - Blake Borgeson, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:6 - Dean Y. Li, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:9 - Franziska Michor, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:12 - Najat Khan, Ph.D.: Chief Executive Officer, President and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Director (member). claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:14 - Namandjé Bumpus, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:16 - Robert Hershberg, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:18 - Zachary Bogue, J.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:20 ## Committees - President and Director (other). Chair: NOT_PUBLISHED. Members: Najat Khan, Ph.D. (member, unknown). committee_id=alpha:committee:recursion-pharmaceuticals-inc:president-and-director ## Executive leadership - David Hallett: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:23 - Nazar Khan: Chief Executive Officer and President [CEO]. Status: current. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:25 - Ben Taylor: Chief Financial Officer and President of Recursion UK [CFO]. Status: unknown. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:22 - Najat Khan, Ph.D.: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:24 ## Governance events - EXECUTIVE_APPOINTED: David Hallett executive of RECURSION PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:x7d9rr1pmh9e9 - CEO_CHANGED: Nazar Khan executive of RECURSION PHARMACEUTICALS, INC., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:heb2xc5znjx - DIRECTOR_APPOINTED: Elaine Sun seat on RECURSION PHARMACEUTICALS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:1psbq8rc8rny3 - DIRECTOR_APPOINTED: Namandjé Bumpus seat on RECURSION PHARMACEUTICALS, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:187narej9tvli - DIRECTOR_APPOINTED: Franziska Michor seat on RECURSION PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:16uig2tzsjcu7 - DIRECTOR_APPOINTED: Najat Khan seat on RECURSION PHARMACEUTICALS, INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:1fpbf451rvwsah - DIRECTOR_APPOINTED: Robert Hershberg seat on RECURSION PHARMACEUTICALS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:1hio82t1fc1gs1 - DIRECTOR_APPOINTED: Zachary Bogue seat on RECURSION PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:13gni0bok7p8 - DIRECTOR_APPOINTED: Zavain Dar seat on RECURSION PHARMACEUTICALS, INC., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:u6gstl12xoek9 - DIRECTOR_APPOINTED: Blake Borgeson seat on RECURSION PHARMACEUTICALS, INC., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:bou1fk1y3f80u - DIRECTOR_APPOINTED: Christopher Gibson seat on RECURSION PHARMACEUTICALS, INC., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:15p4sk0tgx734 - DIRECTOR_APPOINTED: Dean Y. Li seat on RECURSION PHARMACEUTICALS, INC., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-26T04:46:04.593285+00:00. event_id=alpha:event:transition:1kngwr93i2ks3 ## Scoped resources - `alpha://company/recursion-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record - `alpha://company/recursion-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/recursion-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/recursion-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=board - `alpha://company/recursion-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/recursion-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/recursion-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/recursion-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/recursion-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/recursion-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/recursion-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/recursion-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/recursion-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/recursion-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/recursion-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/recursion-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/recursion-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/recursion-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/recursion-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/recursion-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=events - `alpha://company/recursion-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/recursion-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/recursion-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Blake Borgeson: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:5. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Blake Borgeson, Ph.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Christopher Gibson: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:7. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Dean Y. Li: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:8. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Dean Y. Li, M.D., Ph.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Elaine Sun: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Franziska Michor: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Franziska Michor, Ph.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Najat Khan: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:13. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Najat Khan, Ph.D.: Chief Executive Officer, President and Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Namandjé Bumpus: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:15. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Namandjé Bumpus, Ph.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Robert Hershberg: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:17. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Robert Hershberg, M.D., Ph.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Zachary Bogue: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:19. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Zachary Bogue, J.D.: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Zavain Dar: Director. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:21. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c. - Ben Taylor: Chief Financial Officer and President of Recursion UK. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - David Hallett: Chief Scientific Officer. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:23. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:aa0459f25874a75871306cd80c582d405a23bae41d748a6cd4e6604bd38517ce. - Najat Khan, Ph.D.: Chief Executive Officer and President. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8. - Nazar Khan: Chief Executive Officer and President. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:leadership_role:25. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1b724bf2354d2e559676a19aeb4e62875eb132bc75b19dce7485cfc3517e3eeb. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - RECURSION PHARMACEUTICALS, INC.. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48882fd08b1014a016edb583ac6b75228497bb174e8fc0e9c09b0dcabec2c162. ## Entity Status - Public listing published. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48882fd08b1014a016edb583ac6b75228497bb174e8fc0e9c09b0dcabec2c162. ## Published Fact - US. Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48882fd08b1014a016edb583ac6b75228497bb174e8fc0e9c09b0dcabec2c162. ## Security Listing - RXRX (NASDAQ). Claim: alpha:claim:company:deb8693a-bb09-4c17-bce8-ce6df4ea2ed1:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:48882fd08b1014a016edb583ac6b75228497bb174e8fc0e9c09b0dcabec2c162. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:48882fd08b1014a016edb583ac6b75228497bb174e8fc0e9c09b0dcabec2c162: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc). - alpha:projection-evidence:document:e6d6cae329ef7d16924dd69ff4889fbd5ab41f32a6f05bc2633619709795b26c: [DEF 14A rxrx-20260430.htm](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000065/rxrx-20260430.htm). - alpha:projection-evidence:document:e8dba0070441c3244028ad8e955939ad860f50fec404087da78ecc1fe87592d8: [SEC DEF 14A 0001601830-26-000065](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000065/rxrx-20260430.htm). - alpha:projection-evidence:document:aa0459f25874a75871306cd80c582d405a23bae41d748a6cd4e6604bd38517ce: [RXRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000065/rxrx-20260430.htm). - alpha:projection-evidence:document:1b724bf2354d2e559676a19aeb4e62875eb132bc75b19dce7485cfc3517e3eeb: [RXRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1601830/000160183026000065/rxrx-20260430.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/recursion-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/recursion-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/recursion-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/recursion-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-26T12:15:39.493249+00:00; recorded 2026-10-26T12:15:39.493249+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.